Markus Kosch: Bringing Innovative Treatments to People Living With Cancer
Markus Kosch, Head Oncology Europe and Canada at Daiichi Sankyo Europe GmbH, shared a post on LinkedIn:
“Over the past weeks, I’ve had the privilege of spending time with colleagues across several of our European affiliates – in France, Spain, the Netherlands, and Greece.
These visits weren’t about presentations or checklists. They were about dialogue. About listening. And about Kizuna– the deep, human bonds built through trust, collaboration, and shared purpose.
All over Europe, each country brings its own realities, challenges, and opportunities. But while our healthcare systems might differ, our commitment is a shared one: to bring innovative treatments to people living with cancer – faster, more equitably, and in a way that truly reflects local needs.
What unites us across borders is powerful:
- A deep-rooted dedication to patients and progress
- The ambition of our local teams
- And a shared mission to turn science into tangible outcomes
At Daiichi Sankyo Europe GmbH we know that progress doesn’t happen in isolation. It happens through partnerships – within our teams, across our affiliates, and with stakeholders being part of the healthcare ecosystems we serve.
Thank you to everyone who welcomed me so openly.
Let’s keep nurturing these bonds – and building the future of oncology together.”
More posts featuring Markus Kosch.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023